These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34793197)

  • 21. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
    Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
    Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus.
    Mears MC; Rodriguez SE; Schmitz KS; Padilla A; Biswas S; Cajimat MNB; Mire CE; Welch SR; Bergeron É; Alabi CA; Porotto M; Bente DA
    Antiviral Res; 2022 Nov; 207():105401. PubMed ID: 36049554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus.
    Durie IA; Tehrani ZR; Karaaslan E; Sorvillo TE; McGuire J; Golden JW; Welch SR; Kainulainen MH; Harmon JR; Mousa JJ; Gonzalez D; Enos S; Koksal I; Yilmaz G; Karakoc HN; Hamidi S; Albay C; Spengler JR; Spiropoulou CF; Garrison AR; Sajadi MM; Bergeron É; Pegan SD
    Nat Commun; 2022 Nov; 13(1):7298. PubMed ID: 36435827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
    Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
    Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
    Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.
    Lombe BP; Saito T; Miyamoto H; Mori-Kajihara A; Kajihara M; Saijo M; Masumu J; Hattori T; Igarashi M; Takada A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
    Swanson KA; Settembre EC; Shaw CA; Dey AK; Rappuoli R; Mandl CW; Dormitzer PR; Carfi A
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9619-24. PubMed ID: 21586636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).
    Liu D; Li Y; Zhao J; Deng F; Duan X; Kou C; Wu T; Li Y; Wang Y; Ma J; Yang J; Hu Z; Zhang F; Zhang Y; Sun S
    PLoS One; 2014; 9(11):e108419. PubMed ID: 25365026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.
    Kortekaas J; Vloet RP; McAuley AJ; Shen X; Bosch BJ; de Vries L; Moormann RJ; Bente DA
    Vector Borne Zoonotic Dis; 2015 Dec; 15(12):759-64. PubMed ID: 26684523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for antibody-mediated neutralization of Lassa virus.
    Hastie KM; Zandonatti MA; Kleinfelter LM; Heinrich ML; Rowland MM; Chandran K; Branco LM; Robinson JE; Garry RF; Saphire EO
    Science; 2017 Jun; 356(6341):923-928. PubMed ID: 28572385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroepidemiological Investigation of Crimean-Congo Hemorrhagic Fever Virus in Sheep and Camels of Inner Mongolia of China.
    Li Y; Yan C; Liu D; He B; Tu C
    Vector Borne Zoonotic Dis; 2020 Jun; 20(6):461-467. PubMed ID: 32155395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.
    Emmerich P; Mika A; von Possel R; Rackow A; Liu Y; Schmitz H; Günther S; Sherifi K; Halili B; Jakupi X; Berisha L; Ahmeti S; Deschermeier C
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006366. PubMed ID: 29579040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
    Emmerich P; von Possel R; Deschermeier C; Ahmeti S; Berisha L; Halili B; Jakupi X; Sherifi K; Messing C; Borchardt-Lohölter V
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009280. PubMed ID: 33720942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354.
    Kaufmann B; Vogt MR; Goudsmit J; Holdaway HA; Aksyuk AA; Chipman PR; Kuhn RJ; Diamond MS; Rossmann MG
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18950-5. PubMed ID: 20956322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.